Press release
Global Pharmaceutical Drugs Market Projected to Grow at 6.3% CAGR, Reaching $2384.53 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.How Large Will the Pharmaceutical Drugs Market Size By 2025?
The market size of pharmaceutical drugs has significantly expanded in the past few years. The market, which stood at $1747.07 billion in 2024, is projected to escalate to $1864.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this historical growth include advancing healthcare awareness, rising instances of respiratory conditions, lifestyle transformations, enhancements in pharmaceutical research and development (R&D) spending, growing aging demographic, a surge in surgical operations, robust economic improvement in emerging economies and an uptick in approvals for hematology/oncology (cancer) medications.
How Big Is the Pharmaceutical Drugs Market Size Expected to Grow by 2029?
The market size for pharmaceutical drugs is set to experience robust growth in the coming years, expanding to $2384.53 billion in 2029, with a compound annual growth rate (CAGR) of 6.3%. The projected progress during this period can be ascribed to factors such as amplified government backing, heightened access to healthcare, rising investments, swift increase in the elderly population, upsurge in healthcare spending, and growing enlightenment on immunization and vaccination. Noteworthy trends predicted for this period include the utilization of biomarkers in drug creation, multiplied development of next-generation biologics, heightened concentration on personalized medicines, investments towards artificial intelligence (AI) in drug discovery, mixed-drug therapy for respiratory disease treatment, partnerships with wearables firms to augment drug research and development, application of 3D printing in drug production, the invention of microneedle pills for improved drug delivery, and the fabrication of vaccines using MRNA.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Which Key Market Drivers Powering Pharmaceutical Drugs Market Expansion and Growth?
The global disease profile is being significantly influenced by factors such as a surge in sedentary occupations, frenzied lifestyle choices, and evolving consumer preferences, leading to an increasing prevalence of non-communicable illnesses including cancer, diabetes, and cardiovascular conditions. Extended work schedules, diminishing physical exercise, and poor nutrition and drinking habits are substantial contributors to chronic ailments like diabetes. Noncommunicable diseases (NCDs), as per the World Health Organization, result in 41 million casualties each year, which is equivalent to 74% of global deaths. This escalating situation heightens the demand for biologic medication for diabetes treatment. These elements will likely expand the global patient population, propelling the evolution of the pharmaceutical drug market during the projected timeline.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3619&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Pharmaceutical Drugs Market?
Leading corporations in the pharmaceutical drug industry are getting ahead in the market by launching distinctive drugs like Sohonos (palovarotene) capsules. The purpose of Sohonos is to minimize the formation of new heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) patients. Ipsen Biopharmaceuticals, Inc., a biopharmaceutical firm headquartered in France, designed Sohonos (palovarotene), a retinoid that reduces new abnormal bone growth in adults and children aged 8 and above for girls and 10 and above for boys diagnosed with FOP in August 2023. FOP is a rare genetic ailment related to connective tissue that produces heterotopic ossification, or unusual bone formation in regions of the body that usually don't have bone, for instance, in ligaments, tendons, and skeletal muscles. As the disease develops, it impairs movements, results in malformations, and significant disability.
What Are the Emerging Segments in the Pharmaceutical Drugs Market?
The pharmaceutical drugs market covered in this report is segmented -
1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Others
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels
3) By Drug Classification: Branded Drugs, Generic Drugs
4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs, Prescription-Based Drugs
Subsegments:
1) By Cardiovascular Drugs: Antihypertensives, Anticoagulants, Cholesterol-lowering agents
2) By Dermatology Drugs: Topical Corticosteroids, Acne Treatments, Psoriasis Treatments
3) By Gastrointestinal Drugs: Antacids, Proton Pump Inhibitors, Laxatives
4) By Genito-Urinary Drugs: Hormonal Therapies, Anticholinergics for Overactive Bladder, erec*tile Dysfunction Medications
5) By Hematology Drugs: Anticoagulants, Blood Volume Expanders, Erythropoiesis Stimulating Agents
6) By Anti-Infective Drugs: Antibiotics, Antivirals, Antifungals
7) By Metabolic Disorder Drugs: Diabetes Medications, Obesity Management Drugs, Thyroid Hormone Replacement
8) By Musculoskeletal Disorder Drugs: Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease-modifying Antirheumatic Drugs (DMARDs), Muscle Relaxants
9) By Central Nervous System Drugs: Antidepressants, Antipsychotics, Anxiolytics
10) By Others: Chemotherapeutics, Targeted Therapies, Immunotherapies, Glaucoma Treatments, Anti-allergy Drops, Retinal Disease Medications, Asthma Inhalers, COPD Medications, Antihistamines, Vaccines for Infectious Diseases, Therapeutic Nutrients for Chronic Conditions, Calcium Supplements, Iron Supplements, Magnesium Supplements
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3619&type=smp
Who Are the Global Leaders in the Pharmaceutical Drugs Market?
Major companies operating in the pharmaceutical drugs market include Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, União Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Eurolab, Aspen Pharmacare Holdings Limited
Which are the Top Profitable Regional Markets for the Pharmaceutical Drugs Industry?
North America was the largest region in the pharmaceutical drugs market in 2024. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3619
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmaceutical Drugs Market Projected to Grow at 6.3% CAGR, Reaching $2384.53 Billion by 2029 here
News-ID: 4106208 • Views: …
More Releases from The Business Research Company

Future of the Photodynamic Therapy Market: Trends, Innovations, and Key Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Photodynamic Therapy Industry Market Size Be by 2025?
The market size for photodynamic therapy has seen robust growth in the past few years. The market is set to escalate from $1.45 billion in 2024 to $1.55 billion in 2025, reflecting a compound annual growth rate (CAGR)…

Future of the Herpangina Treatment Market: Strategic Analysis and Forecast to 20 …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Herpangina Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for herpangina treatment has seen robust expansion in the past few years. It's projected to escalate from $1.86 billion in 2024 to $1.98 billion in 2025, boasting a compound annual growth rate (CAGR)…

Rising Tide Of Chronic Diseases As A Catalyst For The Health And Wellness Market …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Health And Wellness Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimension of the health and wellness market has seen considerable expansion over the recent past. The market is projected to rise from a value of $6383.68 billion in 2024, to a worth of…

2025-2034 Personal Care Services Market Roadmap: Insights for Competitive Advant …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Services Market Size Growth Forecast: What to Expect by 2025?
Over recent years, the size of the personal care services market has seen swift expansion. The forecasted growth will see it expand from $415.93 billion in 2024, reaching $458.29 billion in 2025, reflecting a compound annual growth…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…